Life Technologies Forms Team to Focus on IP Licensing for PCR, other Products
October 30, 2009
Life Technologies Forms Team to Focus on IP Licensing for PCR, other Products
By Bernadette Toner
The revamped licensing effort has been able to slow a drop-off in royalty revenues from Life Tech's PCR patent estate that had previously been predicted to decline by $30 million in 2009 but has so far only declined by $20 million.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.